GlassScriptPhysician profile
Marcia Consta Peck
NPI 1376569475
$1,786.88
in general payments reported to CMS, 2019-2025
10 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $729 · 2021: $157 · 2022: $32.82 · 2023: $214 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.22 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $450.00 | 2020 | |
| Amgen INC. | $407.19 | 2019-2025 | Prolia |
| Dexcom, INC. | $298.11 | 2019-2023 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Sanofi-Aventis U.S. LLC | $183.53 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $119.31 | 2020 | |
| Ascendis Pharma Endocrinology INC | $114.06 | 2025 | Yorvipath |
| Madrigal Pharmaceuticals | $105.65 | 2025 | Rezdiffra |
| Genzyme Corporation | $72.00 | 2020 | |
| Lilly USA, LLC | $19.25 | 2019 | |
| Companion Medical, INC. | $17.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcia Peck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.